Hedge Funds Are Buying ZIOPHARM Oncology Inc. (ZIOP)
In the eyes of most stock holders, hedge funds are seen as underperforming, outdated financial vehicles of years past.
Amicus Therapeutics Inc. (FOLD)
Market is closed
News
- First
- << Previous
- 71 - 79
Hedge Funds Are Buying Amicus Therapeutics, Inc. (FOLD)
Amicus Therapeutics, Inc. (NASDAQ:FOLD) was in 12 hedge funds' portfolio at the end of March. FOLD shareholders have witnessed an increase in enthusiasm from smart money lately.
Is BioDelivery Sciences International, Inc. (BDSI) Going to Burn These Hedge Funds?
In the financial world, there are plenty of metrics shareholders can use to watch stocks. A pair of the most under-the-radar are hedge fund and insider trading movement.
Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?
In the eyes of most shareholders, hedge funds are seen as underperforming, outdated investment tools of the past.
Amicus Therapeutics, Inc. (FOLD): Are Hedge Funds Right About This Stock?
In the eyes of most stock holders, hedge funds are assumed to be slow, old investment tools of yesteryear.
Are These 3 Stocks Down for the Count?: Ruckus Wireless Inc (RKUS) and More
Horse meat and Wal-Mart Stores, Inc.
This Week in Biotech: AbbVie Inc (ABBV) and More
With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
3 Horrendous Health-Care Stocks This Week: Amicus Therapeutics, Inc. (FOLD) and More
The Ides of March meant bad news for Julius Caesar. Similarly, the week surrounding the Ides of February haven't turned out so well for several health-care stocks.
Issuing More Shares: Good or Bad? - Buckeye Partners, L.P. (BPL), Citigroup Inc. (C) and More
Buckeye Partners, L.P. (NYSE:BPL) recently announced plans to issue additional limited partnership units. Citigroup Inc.
- First
- << Previous
- 71 - 79
Billionaire Hedge Funds
